• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Work study >Reverse logistic process control measures for the pharmaceutical industry supply chain
【24h】

Reverse logistic process control measures for the pharmaceutical industry supply chain

机译：制药行业供应链的逆向物流过程控制措施

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Purpose - The aim of this paper is to analyze the pharmaceutical supply chain using the DMAIC process for improvement of the reverse logistics in a recall to avert the possibility of harm to a consumer.rnDesign/methodology/approach - A framework is used for guiding one towards the responsibilities of the different organizations concerning reverse logistics. This is further developed into a Cause and Effect analysis, performed on the supply chain and the hypothesized problem areas. Improvement concepts were then considered in the use of RFID, consistent information systems and transportation carriers to streamline the supply chain and reducing the risk of counterfeit drugs entering the forward supply chain. FMEA is used to understand the failure modes and the severity of the respective failures in the reverse logistics supply chain.rnFindings - The study yielded interesting and innovative solutions being tested and conceived at the present time, but specific information on the pharmaceutical supply chain was limited. The majority of* the reverse logistics for Pharmaceuticals is handled through third-party providers, and therefore this specific knowledge is well guarded, being a core competency.rnPractical implications - The improvement concepts were found to have managerial impacts such as improved communication flow, and dedicated group(s) to focus on the reverse logistics to remove miscommunication and perception errors. The ability to make improvements, as well as sustain the improvements, will also require significant and consistent management support. Originality/value - The study is a first look at the forward and reverse logistics processes for the pharmaceutical industry supply chain and analysis of potential improvements utilizing DMAIC process. It helps in understanding gaps, suggests measures to reduce them and provides direction for improvements related to the quality of service existing between logistics users, logistics service provider, pharmaceutical firm and customers. The methods of analysis used can also be utilized as a diagnostic tool to understand the weaknesses in the existing supply chain and thus help in identifying the key areas for improvements within the organization.
机译：目的-本文的目的是使用DMAIC流程分析药品供应链，以改善召回中的逆向物流，从而避免对消费者造成伤害的可能性。设计/方法/方法-使用一种框架来指导负责不同组织在逆向物流方面的责任。这将进一步发展为因果分析，对供应链和假设的问题区域进行分析。然后，在使用RFID，一致的信息系统和运输载体来简化供应链并降低假冒药品进入正向供应链的风险时，考虑了改进概念。 FMEA用于了解逆向物流供应链中的故障模式和各个故障的严重性。rn发现-该研究产生了目前正在测试和构想的有趣且创新的解决方案，但有关药品供应链的特定信息有限。药品的大部分*逆向物流都是通过第三方提供商来处理的，因此，这种特殊的知识受到了很好的保护，是一种核心能力。实用意义-发现改进概念对管理产生了影响，例如改善了沟通流程，以及专门小组专注于逆向物流，以消除沟通不畅和感知错误。进行改进以及保持改进的能力也将需要大量且一致的管理支持。原创性/价值-该研究是对制药行业供应链的正向和反向物流流程的首次考察，并利用DMAIC流程分析了潜在的改进。它有助于理解差距，提出减少差距的措施，并为改善物流用户，物流服务提供商，制药公司和客户之间现有的服务质量提供指导。所使用的分析方法也可以用作诊断工具，以了解现有供应链中的弱点，从而帮助确定组织内需要改进的关键领域。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号